Seeking to amend the federal Food, Drug, and Cosmetic Act (FDCA), the bills sponsors frame the proposed legislation as essential to protect patients from untested, unapproved, and potentially dangerous mass compounded drugs. The bill was immediately referred to the House Committee on Energy and Commerce
December 2025: Patients who lost their eyesight after taking Rybelsus can file claims in a newly-approved MDL No
General disclaimer
My cravings feel manageable, movement feels easier, and my mood improved
Are you struggling with constant fatigue, low energy, or difficulty staying focused throughout the day
Despite all the existing studies that aimed to elucidate the underlying mechanism of OTA toxicity, consensus on the primary mechanism of ochratoxicosis has not been reached so far (O'Brien and Dietrich 2005)